| Jennings Hospice 10204 Granger Road, Garfield Heights, OH, 44125 | |
| (216) 472-2684 |
News Archive
Celgene International Sàrl today announced that initial data from an investigator-initiated study of REVLIMID (lenalidomide) plus Rituxan (rituximab) in patients with newly diagnosed indolent B-cell non-Hodgkin's lymphoma (NHL) were presented at the annual meeting of the American Society of Clinical Oncology.
Heartland Information Services, a national provider of medical transcription services, has signed a new three-year agreement with HealthTrust Purchasing Group (HealthTrust), one of the nation's leading health care group purchasing organizations. The agreement covers dictation, transcription and document delivery services.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
A pay-for performance program that offers enhanced reimbursement to oncology practices for prescribing high-quality, evidence-based cancer drugs increased use of these drugs without significantly changing total spending on care, Penn Medicine researchers report in a new study published online in the Journal of Clinical Oncology.
› Verified 5 days ago
| Name | Jennings Hospice |
|---|---|
| Location | 10204 Granger Road, Garfield Heights, Ohio |
| Hospice ID | 361692 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| Accreditation Provider | Accreditation Commission for Health Care (ACHC) |
| SSA county code | 170 |
News Archive
Celgene International Sàrl today announced that initial data from an investigator-initiated study of REVLIMID (lenalidomide) plus Rituxan (rituximab) in patients with newly diagnosed indolent B-cell non-Hodgkin's lymphoma (NHL) were presented at the annual meeting of the American Society of Clinical Oncology.
Heartland Information Services, a national provider of medical transcription services, has signed a new three-year agreement with HealthTrust Purchasing Group (HealthTrust), one of the nation's leading health care group purchasing organizations. The agreement covers dictation, transcription and document delivery services.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
A pay-for performance program that offers enhanced reimbursement to oncology practices for prescribing high-quality, evidence-based cancer drugs increased use of these drugs without significantly changing total spending on care, Penn Medicine researchers report in a new study published online in the Journal of Clinical Oncology.
› Verified 5 days ago
| NPI Number | 1386178341 |
| Organization Name | Northeast Ohio Hospice, Inc. |
| Address | 10204 Granger Rd Garfield Heights, Ohio, 44125 |
| Phone Number | (216)472-2684 |
News Archive
Celgene International Sàrl today announced that initial data from an investigator-initiated study of REVLIMID (lenalidomide) plus Rituxan (rituximab) in patients with newly diagnosed indolent B-cell non-Hodgkin's lymphoma (NHL) were presented at the annual meeting of the American Society of Clinical Oncology.
Heartland Information Services, a national provider of medical transcription services, has signed a new three-year agreement with HealthTrust Purchasing Group (HealthTrust), one of the nation's leading health care group purchasing organizations. The agreement covers dictation, transcription and document delivery services.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
A pay-for performance program that offers enhanced reimbursement to oncology practices for prescribing high-quality, evidence-based cancer drugs increased use of these drugs without significantly changing total spending on care, Penn Medicine researchers report in a new study published online in the Journal of Clinical Oncology.
› Verified 5 days ago
| NPI Number | 1437536547 |
| Organization Name | Jennings Center For Older Adults |
| Address | 10204 Granger Rd Garfield Heights, Ohio, 44125 |
| Phone Number | (216)581-2900 |
News Archive
Celgene International Sàrl today announced that initial data from an investigator-initiated study of REVLIMID (lenalidomide) plus Rituxan (rituximab) in patients with newly diagnosed indolent B-cell non-Hodgkin's lymphoma (NHL) were presented at the annual meeting of the American Society of Clinical Oncology.
Heartland Information Services, a national provider of medical transcription services, has signed a new three-year agreement with HealthTrust Purchasing Group (HealthTrust), one of the nation's leading health care group purchasing organizations. The agreement covers dictation, transcription and document delivery services.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
A pay-for performance program that offers enhanced reimbursement to oncology practices for prescribing high-quality, evidence-based cancer drugs increased use of these drugs without significantly changing total spending on care, Penn Medicine researchers report in a new study published online in the Journal of Clinical Oncology.
› Verified 5 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Celgene International Sàrl today announced that initial data from an investigator-initiated study of REVLIMID (lenalidomide) plus Rituxan (rituximab) in patients with newly diagnosed indolent B-cell non-Hodgkin's lymphoma (NHL) were presented at the annual meeting of the American Society of Clinical Oncology.
Heartland Information Services, a national provider of medical transcription services, has signed a new three-year agreement with HealthTrust Purchasing Group (HealthTrust), one of the nation's leading health care group purchasing organizations. The agreement covers dictation, transcription and document delivery services.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
A pay-for performance program that offers enhanced reimbursement to oncology practices for prescribing high-quality, evidence-based cancer drugs increased use of these drugs without significantly changing total spending on care, Penn Medicine researchers report in a new study published online in the Journal of Clinical Oncology.
› Verified 5 days ago
| Home Health Aides | 0.5 |
| Counselors | 1 |
| Medical Social Workers | 1 |
| Registered Nurses | 2 |
| Other Personnel | 2 |
| Total Employees | 6.5 |
|---|
News Archive
Celgene International Sàrl today announced that initial data from an investigator-initiated study of REVLIMID (lenalidomide) plus Rituxan (rituximab) in patients with newly diagnosed indolent B-cell non-Hodgkin's lymphoma (NHL) were presented at the annual meeting of the American Society of Clinical Oncology.
Heartland Information Services, a national provider of medical transcription services, has signed a new three-year agreement with HealthTrust Purchasing Group (HealthTrust), one of the nation's leading health care group purchasing organizations. The agreement covers dictation, transcription and document delivery services.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
A pay-for performance program that offers enhanced reimbursement to oncology practices for prescribing high-quality, evidence-based cancer drugs increased use of these drugs without significantly changing total spending on care, Penn Medicine researchers report in a new study published online in the Journal of Clinical Oncology.
› Verified 5 days ago
| Jennings Hospice Location: 10204 Granger Road, Garfield Heights, Ohio, 44125 Phone: (216) 472-2684 |